Orexo AB 2021 Credit Investor Presentation

Orexo AB is a pharmaceutical company developing improved pharmaceuticals and digital therapies to address unmet needs in substance use disorders and mental health. This February 2021 credit investor presentation outlines the company's bond issuance offering and its therapeutic approach to growing markets in behavioral health.